Exploiting inflammation for therapeutic gain in pancreatic cancer.

Steele, C W; Jamieson, N B; Evans, T R J; McKay, C J; Sansom, O J; Morton, J P; Carter, C R

Steele, C W; Jamieson, N B; Evans, T R J; McKay, C J; Sansom, O J; Morton, J P; Carter, C R.

Affiliation

Steele CW; The Beatson Institute for Cancer Research, Glasgow G61 1BD, UK.

Br J Cancer ; 108(5): 997-1003, 2013 Mar 19.

Article in En | MEDLINE | ID: mdl-23385734

Subject(s)

Carcinoma, Pancreatic Ductal/immunology; Carcinoma, Pancreatic Ductal/therapy; Immunologic Surveillance; Inflammation/therapy; Pancreatic Neoplasms/immunology; Pancreatic Neoplasms/therapy; Animals; Carcinoma, Pancreatic Ductal/pathology; Chemokines/metabolism; Cytokines/metabolism; Humans; Macrophages/immunology; Molecular Targeted Therapy; Mutation; Neoplasm Metastasis; Pancreatic Neoplasms/genetics; Pancreatic Neoplasms/pathology; Prognosis; Signal Transduction; Tumor Escape; Tumor Microenvironment/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal / Immunologic Surveillance / Inflammation Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2013 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google